As of June 06, 2026, Aligos Therapeutics's top three insider holders are Carole Nuechterlein (Director, 11.03Mn shares), Lawrence Blatt (Chief Executive Officer, 1.85Mn shares), James Paul Scopa (Director, 183.08K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Lawrence Blatt | Chief Executive Officer | 1,847,575 | 0 | 27 Oct, 2023 |
| James Paul Scopa | - | 183,083 | 0 | 27 Oct, 2023 |
| Carole Nuechterlein | - | 0 | 11,025,941 | 27 Oct, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Mar, 2026 | Lesley Ann Calhoun | Stock Option (Right to Buy) | A | 37,485 | $0.00 | 37,485 | D | A |
| 09 Mar, 2026 | Nikhil Aneja | Stock Option (Right to Buy) | A | 9,450 | $0.00 | 9,450 | D | A |
| 09 Mar, 2026 | Julian A. Symons | Stock Option (Right to Buy) | A | 23,310 | $0.00 | 23,310 | D | A |
| 09 Mar, 2026 | Julian A. Symons | Stock Option (Right to Buy) | A | 23,310 | $0.00 | 23,310 | D | A |
| 09 Mar, 2026 | Nikhil Aneja | Stock Option (Right to Buy) | A | 9,450 | $0.00 | 9,450 | D | A |
| 09 Mar, 2026 | Lawrence Blatt | Stock Option (Right to Buy) | A | 105,840 | $0.00 | 105,840 | D | A |
| 16 Jul, 2025 | Lawrence Blatt | Stock Option (Right to Buy) | A | 179,800 | $0.00 | 179,800 | D | A |
| 16 Jul, 2025 | Julian A. Symons | Stock Option (Right to Buy) | A | 16,000 | $0.00 | 16,000 | D | A |
| 16 Jul, 2025 | Julian A. Symons | Stock Option (Right to Buy) | A | 16,000 | $0.00 | 16,000 | D | A |
| 16 Jul, 2025 | Lesley Ann Calhoun | Stock Option (Right to Buy) | A | 40,185 | $0.00 | 40,185 | D | A |
| 25 Jun, 2025 | Carole Nuechterlein | Stock Option (Right to Buy) | A | 5,860 | $0.00 | 5,860 | D | A |
| 25 Jun, 2025 | Margarita Chavez | Stock Option (Right to Buy) | A | 5,860 | $0.00 | 5,860 | D | A |
| 25 Jun, 2025 | Bridget A Martell | Stock Option (Right to Buy) | A | 5,860 | $0.00 | 5,860 | D | A |
| 25 Jun, 2025 | Heather Preston | Stock Option (Right to Buy) | A | 5,860 | $0.00 | 5,860 | D | A |
| 25 Jun, 2025 | Carole Nuechterlein | Stock Option (Right to Buy) | A | 5,860 | $0.00 | 5,860 | D | A |
| 25 Jun, 2025 | Margarita Chavez | Stock Option (Right to Buy) | A | 5,860 | $0.00 | 5,860 | D | A |
| 25 Jun, 2025 | Heather Preston | Stock Option (Right to Buy) | A | 5,860 | $0.00 | 5,860 | D | A |
| 25 Jun, 2025 | Peter Hirth | Stock Option (Right to Buy) | A | 5,860 | $0.00 | 5,860 | D | A |
| 25 Jun, 2025 | James Paul Scopa | Stock Option (Right to Buy) | A | 5,860 | $0.00 | 5,860 | D | A |
| 28 Feb, 2025 | Julian A. Symons | Stock Option (Right to Buy) | A | 21,693 | $0.00 | 21,693 | D | A |